![Gregory Norden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Norden
Directeur/Membre du Conseil chez
PRAXIS PRECISION MEDICINES, INC.
Fortune : 21 M $ au 31/05/2026
Profil
Gregory Norden currently works at Zoetis, Inc., as Independent Director from 2014, RP Management LLC, as Director, G9 Capital Group LLC, as Managing Director from 2010, Praxis Precision Medicines, Inc., as Independent Director from 2019, Anthos Therapeutics, Inc., as Director from 2019, and Royalty Pharma Plc, as Independent Director from 2020.
Mr. Norden also formerly worked at AMAG Pharma USA, Inc., as Director from 2013 to 2014, Human Genome Sciences, Inc., as Independent Director from 2011 to 2012, Univision Communications, Inc., as Director, Welch Allyn, Inc., as Director, Greatwide Logistics Services LLC, as Director, Univision Holdings, Inc., as Director, Entasis Therapeutics, Inc., as Independent Director, Entasis Therapeutics Holdings, Inc., as Independent Director, NS Wind Down Co., Inc., as Independent Director from 2012 to 2024, Wyeth Pharmaceuticals LLC, as Chief Financial Officer & Executive Vice President, Arthur Andersen LLP, as Audit Manager, Ayerst Laboratories, Inc., as Vice President-Finance from 1996 to 1999, Arthur Andersen & Co., as Audit Manager, and Wyeth LLC, as Chief Financial Officer & Senior Vice President from 1989 to 2009.
Mr. Norden received his undergraduate degree from State University of New York College at Plattsburgh and graduate degree from Long Island University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 196 348 ( 0,04 % ) | 11 M $ | 31/05/2026 | |
RPI US Partners 2019 LP
 RPI US Partners 2019 LP Financial ConglomeratesFinance Functions as an investment fund 0,07 % | 08/08/2025 | 141 474 ( 0,07 % ) | 8 M $ | 31/05/2026 |
| 20/03/2026 | 18 167 ( 0 % ) | 1 M $ | 31/05/2026 | |
| 10/06/2026 | 1 559 ( 0,01 % ) | 545 603 $ | 31/05/2026 |
Postes actifs de Gregory Norden
| Sociétés | Poste | Début |
|---|---|---|
| ZOETIS INC. | Directeur/Membre du Conseil | 01/01/2013 |
| ROYALTY PHARMA PLC | Directeur/Membre du Conseil | 11/02/2020 |
| PRAXIS PRECISION MEDICINES, INC. | Directeur/Membre du Conseil | 01/03/2019 |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Directeur/Membre du Conseil | 01/01/2019 |
RP Management LLC
 RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Directeur/Membre du Conseil | - |
G9 Capital Group LLC
 G9 Capital Group LLC Financial ConglomeratesFinance Provides investment services | Directeur Général | 01/01/2010 |
Anciens postes connus de Gregory Norden
| Sociétés | Poste | Fin |
|---|---|---|
| NS WIND DOWN CO., INC. | Directeur/Membre du Conseil | 26/06/2024 |
Welch Allyn, Inc.
 Welch Allyn, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical diagnostic and therapeutic devices | Directeur/Membre du Conseil | 01/01/2015 |
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/01/2014 |
| ░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Gregory Norden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
AMAG Pharma USA, Inc.
AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Univision Communications, Inc.
 Univision Communications, Inc. BroadcastingConsumer Services Provides television, radio and digital streaming network services | Consumer Services |
Welch Allyn, Inc.
Welch Allyn, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical diagnostic and therapeutic devices | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Zoetis, Inc.
 Zoetis, Inc. Pharmaceuticals: MajorHealth Technology Develops animal vaccines and prescriptions medicines | Health Technology |
State University of New York College at Plattsburgh
 State University of New York College at Plattsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NS Wind Down Co., Inc.
 NS Wind Down Co., Inc. Medical SpecialtiesHealth Technology Develops and manufactures life science tools for translational research and molecular diagnostic products | Health Technology |
Greatwide Logistics Services LLC
 Greatwide Logistics Services LLC Air Freight/CouriersTransportation Provides transportation, truckload management and logistics services | Transportation |
Univision Holdings, Inc.
 Univision Holdings, Inc. BroadcastingConsumer Services Provides television broadcasting services | Consumer Services |
Ayerst Laboratories, Inc. | |
RP Management LLC
RP Management LLC Financial ConglomeratesFinance Provides biopharma royalty transactions services | Finance |
G9 Capital Group LLC
G9 Capital Group LLC Financial ConglomeratesFinance Provides investment services | Finance |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for infectious diseases | Health Technology |
Praxis Precision Medicines, Inc.
 Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Entasis Therapeutics Holdings, Inc.
 Entasis Therapeutics Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biopharmaceutical company that engages in development of antibacterial products | Commercial Services |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Arthur Andersen & Co.
 Arthur Andersen & Co. Miscellaneous Commercial ServicesCommercial Services Operates as an accounting firm | Commercial Services |
